Should whole-genome sequencing become part of newborn screening?

March 26, 2014

Should whole-genome sequencing be used in the public-health programs that screen newborns for rare conditions? That question is likely to stir debate in coming years in many of the more-than-60 countries that provide newborn screening, as whole-genome sequencing (WGS) becomes increasingly affordable and reliable. Newborn screening programs – which involve drawing a few drops of blood from a newborn's heel – have been in place since the late 1960s, and are credited with having saved thousands of lives by identifying certain genetic, endocrine or metabolic disorders that can be treated effectively when caught early enough. Advocates of routine WGS for newborns argue that the new technology could help detect and manage a wider array of disorders.

But the possibility of making part of routine screening programs for newborns raises ethical, legal and social issues that should be weighed carefully, according to researchers at McGill University's Department of Human Genetics in Montreal.

In an article published March 26 in the journal Science Translational Medicine, Prof. Bartha M. Knoppers and colleagues lay out key questions and considerations to be addressed. "Any change in newborn screening programs should be guided by what's in the best interests of the child," says Prof. Knoppers, who is Director of the Centre of Genomics and Policy at McGill. "We must also tread carefully in interpreting the scientific validity and clinical usefulness of WGS results."

The researchers outline the following considerations:

  • What information to report? Using WGS in newborn screening could generate vast amounts of information – including incidental findings such as paternity information or reproductive risks. What's more, health-related information can include non-validated or poorly predictive results, or may involve adult-onset conditions. One possible solution: perform WGS but have a list of pediatric conditions to be communicated to parents; other results could be retrieved for later disclosure, when they gain scientific validity and clinical usefulness, or when they can be reported to the "mature" child directly.
  • Impact on health care systems. If WGS in newborn screening is implemented, systems would have to be revamped to handle the massive amount of information generated. The added information could also lead to more false-positive results, imposing a big burden on families and on the resources of a health-care system.
  • Mandatory vs. voluntary. Most newborn screening programs currently are mandated by law or use presumed . Should parental consent be required for screening that doesn't stand to directly benefit the infant during childhood?
  • Educating health professionals and parents. Many doctors have little training in genetics, so health professionals and parents will need more education in genetics and genomics.
  • Communicating results over time. The validity of tests and the communication and understanding of results over time pose numerous challenges for doctors and families.
  • Ensuring treatment and follow-up. When treatment becomes available, a newborn screening report card would be invaluable on an individual basis, especially for single-gene disorders.
  • Validated variants. An important challenge in WGS is the ability to offer a standardized and accurate interpretation of genetic variants.
  • Storage of data. Should raw data be stored in the patient's file? If so, under what conditions and for how long?
  • Insurability. Data obtained through WGS newborn screening would be part of the medical record, potentially leading to issues regarding insurability.

"Without clear policy direction and public discussion on the possible future integration (or not) of WGS into , more parents in years ahead may choose to pay for whole-genome sequencing through private testing services," says article co-author Karine Sénécal, an academic associate at the Centre of Genomics and Policy at McGill. "Medical and public education programs need to be put in place so that people understand the limits of whole-genome sequencing."

Explore further: Sickle cell trait: Neglected opportunities in the era of genomic medicine

More information: "Whole-Genome Sequencing in Newborn Screening Programs," by B.M. Knoppers; et al. Science Translational Medicine, 2014.

Related Stories

Sickle cell trait: Neglected opportunities in the era of genomic medicine

March 6, 2014
(Boston)—While acknowledging the potential of genomics to prevent and treat disease, researchers from Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) believe it is long past due to use current ...

New guidelines issued for genetic screening in newborns, children

February 21, 2013
(HealthDay)— New guidelines on testing newborns and children for genetic diseases recommend screening for childhood diseases but note that testing for diseases that strike in adulthood may not be worthwhile.

Scientific progress could be casualty in public health vs. privacy debate over newborn blood samples

November 7, 2012
The tremendous potential public health benefits of research with blood samples left over after routine newborn screening must not be lost amidst controversy and litigation, say medical and bioethics experts in a commentary ...

Ethical issues as scientists peek into baby genes

October 7, 2013
Little Amelia Sloan is a pioneer: Shortly after her birth, scientists took drops of the healthy baby's blood to map her genetic code.

Parents seen as critical stakeholders in expanding newborn screening

June 21, 2012
Parents must be considered when states decide to expand genetic screening programs for newborns, according to a new study that looked at mandatory testing panels and political pressure by advocacy groups.

Recommended for you

Phenotype varies for presumed pathogenic variants in KCNB1

August 16, 2017
(HealthDay)—De novo KCNB1 missense and loss-of-function variants are associated with neurodevelopmental disorders, with or without seizures, according to a study published online Aug. 14 in JAMA Neurology.

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Active non-coding DNA might help pinpoint genetic risk for psychiatric disorders

August 16, 2017
Northwestern Medicine scientists have demonstrated a new method of analyzing non-coding regions of DNA in neurons, which may help to pinpoint which genetic variants are most important to the development of schizophrenia and ...

Evolved masculine and feminine behaviors can be inherited from social environment

August 15, 2017
The different ways men and women behave, passed down from generation to generation, can be inherited from our social environment - not just from genes, experts have suggested.

Attitudes on human genome editing vary, but all agree conversation is necessary

August 10, 2017
In early August 2017, an international team of scientists announced they had successfully edited the DNA of human embryos. As people process the political, moral and regulatory issues of the technology—which nudges us closer ...

Two genes help older brain gain new cells

August 10, 2017
Two genes act as molecular midwives to the birth of neurons in adult mammals and when inactivated in mice cause symptoms of Fragile X Syndrome, a major cause of mental retardation, a new Yale University study has shown.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.